NRBP — Neorich Biopharma Tech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Neorich Biopharma Tech, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.012	0.025	0.008	0.001	0
Net Total Accounts Receivable
Net Total Receivables	0	0	0	0.001	0.001
Total Inventory
Prepaid Expenses
Total Current Assets	0.266	0.373	0.209	0.033	0.009
Net Property, Plant And Equipment	0	—	—	—	—
Long Term Notes Receivable
Total Assets	0.266	0.373	0.209	0.122	0.098
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.17	2.03	1.91	2.21	3.14
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	3.15	2.02	1.98	2.26	3.19
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-2.89	-1.65	-1.78	-2.13	-3.09
Total Liabilities & Shareholders' Equity	0.266	0.373	0.209	0.122	0.098
Total Common Shares Outstanding
Total Preferred Shares Outstanding